Effects of acute normoxic hypoxia on brain-derived neurotrophic factor (BDNF) and cognition

Effects of acute normoxic hypoxia on brain-derived neurotrophic factor (BDNF) and cognition - Acute Hypoxia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00034492

Enrollment

Registered

2024-06-18

Start date

2023-02-01

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BDNF/Cognition

Interventions

Group 1: Acute Hypoxia (90 minutes 80-85%) Group 2: Normoxic condition (room air condition)

Eligibility

Sex/Gender

All

Age

18 Years to 30 Years

Inclusion criteria

Inclusion criteria: no

Exclusion criteria

Exclusion criteria: respiratory diseases (e. g. bronchial asthma, COPD), cardiovascular/neurological/psychiatric diseases, drug/alcohol use in the 24 h preceding the examination, history of altitude sickness, a stay at altitude within the last 3 months or regular smoking habits

Design outcomes

Primary

Measure	Time frame
BDNF serum/plasma (pre-post changes)	—

Secondary

Measure	Time frame
Cognition *neuropsychological tests (digit span test, d2 attention task)	—

Countries

Germany

Contacts

Public ContactPatrick Müller

Universitätsklinik Magdeburg

patrick.mueller@med.ovgu.de03916713201

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026